Insect Cell Lines Market - Regional Analysis
North American Market Insights
The insect cell lines market in North America industry is expected to account for largest revenue share of 35% by 2035, impelled by increasing spending in the production of vaccines. This, as a result, may lead to increasing development of vaccines in the region which is expected to drive the demand for insect cell lines. For instance, as of 2020, American biopharmaceutical companies worked on over 250 vaccines to prevent and treat diseases including cancer, and other autoimmune disorders.
The US government spent over USD 31 billion on the research, development, and acquisition of mRNA COVID-19 vaccines, with significant sums spent in the three decades before the pandemic and through March 2022.
European Market Insights
The Europe insect cell lines market is estimated to be the second largest, during the forecast period led by rising spending in research & development in the healthcare industry. This has led to an increase in focus on research and development in the area of creative medicines by the pharmaceutical industry in the region which is essential if diseases and disorders are to be treated efficiently. In Europe, the research-based pharmaceutical business alone spent around €37 billion on R&D in 2019 and over €35 billion in 2020.
